Kapat

INT - EN


Select a country and, if applicable, a language.

Please note that some articles are only available in English.

Makaleye genel bakış

Relief of acute cough by cough syrup with mucoprotection


Two randomised, blind, controlled, multicentre studies investigated the therapeutic effect of a chemical and mechanical barrier in the upper airways produced by polysaccharide-resin-honey based cough ...

Makaleye git
Yazar: Tobias Mück, PhDEFSM: 2021;1:210004DOI: 10.52778/efsm.21.0004Tarih: 16.08.2021

Female-specific characteristics in the occurrence and treatment of constipation


Constipation not only has an impact on daily bowel movements, but also on the well-being of the persons concerned. An online survey of more than 5,000 people showed that women are often more extensive ...

Makaleye git
Yazar: Sabine Landes, PhDEFSM: 2021;1:210006DOI: 10.52778/efsm.21.0006Tarih: 16.08.2021

Pharmacokinetics of ibuprofen: comparison of the fixed combination of ibuprofen plus caffeine with …

Results of two single-dose studies (randomised, single centre, crossover, open-label)


Analgesics containing readily soluble ibuprofen (e.g. as the lysinate) were developed with the aim of ensuring a more rapid relief of pain than ibuprofen acid through faster absorption in the gastroin ...

Makaleye git
Yazar: Thomas Weiser, PhDEFSM: 2021;1:210007DOI: 10.52778/efsm.21.0007Tarih: 16.08.2021

Efficacy, safety and tolerability of the fixed combination of ibuprofen (400 mg) and caffeine (100 …

Results of a clinical study (randomised, placebo-controlled, double-blind)


Does combining ibuprofen with caffeine have advantages over ibuprofen alone in the treatment of acute pain? A randomised, placebo-controlled, double-blind study compared efficacy, safety and tolerabil ...

Makaleye git
Yazar: Thomas Weiser, PhDEFSM: 2021;1:210008DOI: 10.52778/efsm.0008Tarih: 16.08.2021

Treatment of acute pain: comparison of the efficacy of ibuprofen lysinate and ibuprofen


Relief that is rapid and effective is wanted when treating pain. A double-blind, placebo-controlled study investigated the efficacy, safety and tolerability of ibuprofen lysinate, ibuprofen acid and p ...

Makaleye git
Yazar: Thomas Weiser, PhDEFSM: 2021;1:210012DOI: 10.52778/efsm.21.0012Tarih: 16.08.2021

Recent meta-analysis on the efficacy of peppermint oil in irritable bowel syndrome


The meta-analysis demonstrated that peppermint oil is an effective and safe medicinal agent for treating the symptoms of irritable bowel syndrome. In seven clinical studies, peppermint oil was clearly ...

Makaleye git
Yazar: Harald Weigmann, PhDEFSM: 2021;1:210013DOI: 10.52778/efsm.21.0013Tarih: 16.08.2021

Caffeine – stimulating and aromatic: but safe!


The European Food Safety Authority has undertaken a comprehensive risk assessment and concluded that life-long regular consumption of caffeine of up to 400 mg daily from the age of 18 by healthy adult ...

Makaleye git
Yazar: Thomas Weiser, PhDEFSM: 2021;1:210014DOI: 10.52778/efsm.21.0014Tarih: 16.08.2021

Do caffeine-containing combination analgesics cause sleepless nights?


No relevant effects on the sleep quality of subjects were found in two studies in which ibuprofen combined with 100 mg caffeine was taken three times daily. Of a total of 538 patients, medication-indu ...

Makaleye git
Yazar: Thomas Weiser, PhDEFSM: 2021;1:210015DOI: 10.52778/efsm.21.0015Tarih: 16.08.2021

Analgesics with effect enhancers – combination analgesics with caffeine


A review by the Cochrane Collaboration compared the analgesic effects of a common analgesic with a combination of the analgesic and caffeine. The addition of caffeine significantly increased the propo ...

Makaleye git
Yazar: Thomas Weiser, PhDEFSM: 2021;1:210016DOI: 10.52778/efsm.21.0016Tarih: 16.08.2021

Fall asleep quickly – wake up refreshed!


Various causes, including stress and increased media consumption, lead to a reduction or even total absence of the release of endogenous melatonin, followed by problems falling asleep. According to th ...

Makaleye git
Yazar: Tanja Schütt, PhDEFSM: 2021;1:210017DOI: 10.52778/efsm.21.0017Tarih: 16.08.2021